Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Seres Therapeutics (MCRB) Other Operating Expenses: 2021-2024

Historic Other Operating Expenses for Seres Therapeutics (MCRB) over the last 2 years, with Dec 2024 value amounting to $3.5 million.

  • Seres Therapeutics' Other Operating Expenses was N/A to $736,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year change of. This contributed to the annual value of $3.5 million for FY2024, which is N/A change from last year.
  • Seres Therapeutics' Other Operating Expenses amounted to $3.5 million in FY2024, which was up 103.93% from $1.7 million recorded in FY2021.
  • Over the past 5 years, Seres Therapeutics' Other Operating Expenses peaked at $3.5 million during FY2024, and registered a low of $1.7 million during FY2021.
  • Over the past 1 years, Seres Therapeutics' median Other Operating Expenses value was $3.5 million (recorded in 2024), while the average stood at $3.5 million.